Drug recall · December 7, 2016
Phenazopyridine Hydrochloride Tablets recall
Why: CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Phenazopyridine Hydrochloride Tablets, USP, 100 mg, 100 count bottles, Rx only, Manufactured for: Nationwide Laboratories LLC, Iselin, New Jersey 08830, NDC 42937-701-10.
- Lots / codes
Lot #: 28161501, Exp 03/17; 28161502, 28161503, Exp 08/17; 28161601, 28161602, Exp 01/18
- Quantity
- 6,333,669 tablets
- Company
- Nationwide Laboratories, LLC, Iselin, NJ
- Distribution
- Nationwide in USA and Puerto Rico
- Initiated
- October 28, 2016 · Voluntary: Firm initiated
- Classified
- December 1, 2016
- Reported
- December 7, 2016
- Ended
- May 17, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Phenazopyridine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.